Copyright Reports & Markets. All rights reserved.

Global Meningococcal Conjugate Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Menactra
    • 1.4.3 Menveo
    • 1.4.4 NeisVac-C
    • 1.4.5 Nimenrix
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Meningococcal Conjugate Market Share by Application: 2020 VS 2026
    • 1.5.2 Children
    • 1.5.3 Preteens or Teens
    • 1.5.4 Adults
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Meningococcal Conjugate Market Perspective (2015-2026)
  • 2.2 Global Meningococcal Conjugate Growth Trends by Regions
    • 2.2.1 Meningococcal Conjugate Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Meningococcal Conjugate Historic Market Share by Regions (2015-2020)
    • 2.2.3 Meningococcal Conjugate Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Meningococcal Conjugate Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Meningococcal Conjugate Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Meningococcal Conjugate Players by Market Size
    • 3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2015-2020)
    • 3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Meningococcal Conjugate Market Concentration Ratio
    • 3.2.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2019
  • 3.3 Meningococcal Conjugate Key Players Head office and Area Served
  • 3.4 Key Players Meningococcal Conjugate Product Solution and Service
  • 3.5 Date of Enter into Meningococcal Conjugate Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Meningococcal Conjugate Historic Market Size by Type (2015-2020)
  • 4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Meningococcal Conjugate Market Size by Application (2015-2020)
  • 5.2 Global Meningococcal Conjugate Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Meningococcal Conjugate Market Size (2015-2020)
  • 6.2 Meningococcal Conjugate Key Players in North America (2019-2020)
  • 6.3 North America Meningococcal Conjugate Market Size by Type (2015-2020)
  • 6.4 North America Meningococcal Conjugate Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Meningococcal Conjugate Market Size (2015-2020)
  • 7.2 Meningococcal Conjugate Key Players in Europe (2019-2020)
  • 7.3 Europe Meningococcal Conjugate Market Size by Type (2015-2020)
  • 7.4 Europe Meningococcal Conjugate Market Size by Application (2015-2020)

8 China

  • 8.1 China Meningococcal Conjugate Market Size (2015-2020)
  • 8.2 Meningococcal Conjugate Key Players in China (2019-2020)
  • 8.3 China Meningococcal Conjugate Market Size by Type (2015-2020)
  • 8.4 China Meningococcal Conjugate Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Meningococcal Conjugate Market Size (2015-2020)
  • 9.2 Meningococcal Conjugate Key Players in Japan (2019-2020)
  • 9.3 Japan Meningococcal Conjugate Market Size by Type (2015-2020)
  • 9.4 Japan Meningococcal Conjugate Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Meningococcal Conjugate Market Size (2015-2020)
  • 10.2 Meningococcal Conjugate Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Meningococcal Conjugate Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Meningococcal Conjugate Market Size by Application (2015-2020)

11 India

  • 11.1 India Meningococcal Conjugate Market Size (2015-2020)
  • 11.2 Meningococcal Conjugate Key Players in India (2019-2020)
  • 11.3 India Meningococcal Conjugate Market Size by Type (2015-2020)
  • 11.4 India Meningococcal Conjugate Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Meningococcal Conjugate Market Size (2015-2020)
  • 12.2 Meningococcal Conjugate Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Meningococcal Conjugate Market Size by Type (2015-2020)
  • 12.4 Central & South America Meningococcal Conjugate Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Sanofi Pasteur
    • 13.1.1 Sanofi Pasteur Company Details
    • 13.1.2 Sanofi Pasteur Business Overview
    • 13.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
    • 13.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2015-2020))
    • 13.1.5 Sanofi Pasteur Recent Development
  • 13.2 Pfizer
    • 13.2.1 Pfizer Company Details
    • 13.2.2 Pfizer Business Overview
    • 13.2.3 Pfizer Meningococcal Conjugate Introduction
    • 13.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.2.5 Pfizer Recent Development
  • 13.3 Glaxo Smith Kline
    • 13.3.1 Glaxo Smith Kline Company Details
    • 13.3.2 Glaxo Smith Kline Business Overview
    • 13.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
    • 13.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.3.5 Glaxo Smith Kline Recent Development
  • 13.4 Hualan Biological Engineering
    • 13.4.1 Hualan Biological Engineering Company Details
    • 13.4.2 Hualan Biological Engineering Business Overview
    • 13.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
    • 13.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.4.5 Hualan Biological Engineering Recent Development
  • 13.5 JN International Medical Corporation
    • 13.5.1 JN International Medical Corporation Company Details
    • 13.5.2 JN International Medical Corporation Business Overview
    • 13.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
    • 13.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.5.5 JN International Medical Corporation Recent Development
  • 13.6 Baxter International
    • 13.6.1 Baxter International Company Details
    • 13.6.2 Baxter International Business Overview
    • 13.6.3 Baxter International Meningococcal Conjugate Introduction
    • 13.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.6.5 Baxter International Recent Development
  • 13.7 Merck
    • 13.7.1 Merck Company Details
    • 13.7.2 Merck Business Overview
    • 13.7.3 Merck Meningococcal Conjugate Introduction
    • 13.7.4 Merck Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.7.5 Merck Recent Development
  • 13.8 Serum Institute of India
    • 13.8.1 Serum Institute of India Company Details
    • 13.8.2 Serum Institute of India Business Overview
    • 13.8.3 Serum Institute of India Meningococcal Conjugate Introduction
    • 13.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.8.5 Serum Institute of India Recent Development
  • 13.9 Biomed
    • 13.9.1 Biomed Company Details
    • 13.9.2 Biomed Business Overview
    • 13.9.3 Biomed Meningococcal Conjugate Introduction
    • 13.9.4 Biomed Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.9.5 Biomed Recent Development
  • 13.10 Novartis
    • 13.10.1 Novartis Company Details
    • 13.10.2 Novartis Business Overview
    • 13.10.3 Novartis Meningococcal Conjugate Introduction
    • 13.10.4 Novartis Revenue in Meningococcal Conjugate Business (2015-2020)
    • 13.10.5 Novartis Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Meningococcal Conjugate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Sanofi Pasteur
    Pfizer
    Glaxo Smith Kline
    Hualan Biological Engineering
    JN International Medical Corporation
    Baxter International
    Merck
    Serum Institute of India
    Biomed
    Novartis

    Market segment by Type, the product can be split into
    Menactra
    Menveo
    NeisVac-C
    Nimenrix
    Others
    Market segment by Application, split into
    Children
    Preteens or Teens
    Adults

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now